trending Market Intelligence /marketintelligence/en/news-insights/trending/7YBE0rc9rw6m0RxF_SV6Zw2 content esgSubNav
In This List

Amedica refiles FDA application for cervical implant

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Amedica refiles FDA application for cervical implant

Amedica Corp. has refiled an application with the U.S. FDA with a modified cancellous-structured ceramic-based cervical implant that is comparable to the company's commercially available ValeoC cervical implants.

The company made the filing after encouraging results from a recent study showing rapid bone growth into porous silicon nitride.

Explants of Amedica's porous silicon nitride from a large-animal model demonstrated bone healing into the material four weeks after implantation.